FOLD vs IT · rev $528.3M vs P/E 16, rev $6.27B
Amicus Therapeutics Inc (FOLD) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
FOLD currently screens at market cap $1.80B. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the FOLD and IT stock pages for the full models.
Not investment advice.